Literature DB >> 30312730

Hematopoietic growth factors and tumor angiogenesis.

Domenico Ribatti1, Roberto Tamma2.   

Abstract

Angiogenesis is regulated by numerous "classic" factors such as vascular endothelial growth factor (VEGF) and many other endogenous "non-classic"peptides, including erythropoietin (Epo), and granulocyte-/granulocyte macrophage colony stimulating factor (G-/GM-CSF). The latter play an important regulatory role in angiogenesis, especially under pathological conditions and constitute a crosslink between angiogenesis and hematopoiesis. This article reviews studies on the ability of hematopoietic cytokines to affect several endothelial cell functions in tumor angiogenesis. These findings in all these studies support the hypothesis formulated at the beginning of this century that a common ancestral cell, the hemangioblast, gives rise to cells of both the endothelial and the hematopoietic lineages.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Erythropoietin; G-CSF; GM-CSF; Tumor growth; VEGF

Mesh:

Substances:

Year:  2018        PMID: 30312730     DOI: 10.1016/j.canlet.2018.10.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Vascular biology of uterine fibroids: connecting fibroids and vascular disorders.

Authors:  Gregory W Kirschen; Abdelrahman AlAshqar; Mariko Miyashita-Ishiwata; Lauren Reschke; Malak El Sabeh; Mostafa A Borahay
Journal:  Reproduction       Date:  2021-07-08       Impact factor: 3.923

2.  Vasculogenic Mimicry Formation Is Associated with Erythropoietin Expression but Not with Erythropoietin Receptor Expression in Cervical Squamous Cell Carcinoma.

Authors:  Yue-Jie Li; Xin Qing; Qing-Xu Tao; Li Xiang; Li Gong; Tie-Jun Zhou
Journal:  Biomed Res Int       Date:  2019-02-21       Impact factor: 3.411

3.  Human Skin-Derived Mast Cells Spontaneously Secrete Several Angiogenesis-Related Factors.

Authors:  Cody McHale; Zahraa Mohammed; Gregorio Gomez
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 4.  3D Bioprinting for Vascularized Tissue-Engineered Bone Fabrication.

Authors:  Fei Xing; Zhou Xiang; Pol Maria Rommens; Ulrike Ritz
Journal:  Materials (Basel)       Date:  2020-05-15       Impact factor: 3.623

5.  Involvement and Targeted Intervention of Mortalin-Regulated Proteome Phosphorylated-Modification in Hepatocellular Carcinoma.

Authors:  Ye Yang; Ming Jin; Yi Dai; Wenqi Shan; Shuai Chen; Rong Cai; Haojun Yang; Liming Tang; Lei Li
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

Review 6.  Strategies for Remodeling the Tumor Microenvironment Using Active Ingredients of Ginseng-A Promising Approach for Cancer Therapy.

Authors:  Mo Li; Xin Wang; Ying Wang; Shunchao Bao; Qing Chang; Linlin Liu; Shuai Zhang; Liwei Sun
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

Review 7.  Treating Metastatic Brain Cancers With Stem Cells.

Authors:  Nadia Sadanandan; Alex Shear; Beverly Brooks; Madeline Saft; Dorothy Anne Galang Cabantan; Chase Kingsbury; Henry Zhang; Stefan Anthony; Zhen-Jie Wang; Felipe Esparza Salazar; Alma R Lezama Toledo; Germán Rivera Monroy; Joaquin Vega Gonzales-Portillo; Alexa Moscatello; Jea-Young Lee; Cesario V Borlongan
Journal:  Front Mol Neurosci       Date:  2021-11-24       Impact factor: 5.639

Review 8.  The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.

Authors:  Yingli Guo; Yajuan Xie; Yao Luo
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

9.  Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.

Authors:  Marc Corbera-Bellalta; Roser Alba-Rovira; Sujatha Muralidharan; Georgina Espígol-Frigolé; Roberto Ríos-Garcés; Javier Marco-Hernández; Amanda Denuc; Farah Kamberovic; Patricia Pérez-Galán; Alexandra Joseph; Annalisa D'Andrea; Kent Bondensgaard; Maria C Cid; John F Paolini
Journal:  Ann Rheum Dis       Date:  2022-01-19       Impact factor: 19.103

10.  Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA.

Authors:  Meicen Zhou; Wenbao Lu; Bingwei Li; Xiaochen Yuan; Mingming Liu; Jianqun Han; Xueting Liu; Ailing Li
Journal:  Int J Biol Sci       Date:  2021-07-13       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.